Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
D000661:Amphetamine / Q000037:antagonists & inhibitors; D000818:Animals; D001058:Apomorphine / Q000037:antagonists & inhibitors; D001522:Behavior, Animal / Q000187:drug effects; D001562:Benzimidazoles / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D001763:Blepharoptosis / Q000139:chemically induced; D001833:Body Temperature Regulation / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D002375:Catalepsy / Q000139:chemically induced; D002415:Cats; D002746:Chlorpromazine / Q000494:pharmacology* / Q000633:toxicity; D003692:Delayed-Action Preparations; D004285:Dogs; D005260:Female; D006168:Guinea Pigs; D006220:Haloperidol / Q000494:pharmacology* / Q000633:toxicity; D000882:Haplorhini; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008722:Methods; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D011618:Psychotic Disorders / Q000188:drug therapy; D011817:Rabbits; D051381:Rats; D013552:Swine; D014149:Tranquilizing Agents / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D001562:Benzimidazoles; D003692:Delayed-Action Preparations; D006634:Histamine H1 Antagonists; D014149:Tranquilizing Agents; D014662:Vasoconstrictor Agents; D000661:Amphetamine; D006220:Haloperidol; D001058:Apomorphine; D002746:Chlorpromazine; D009638:Norepinephrine